Clinical Trial Update: Efficacy and Tolerability of Beta Hydroxybutyrate Ester in Patients With Amyotrophic Lateral Sclerosis (ALS) [NA]

View source ↗

Summary

Clinical trial update noting recruitment for a study evaluating the efficacy and tolerability of beta hydroxybutyrate ester in patients with amyotrophic lateral…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Beta Hydroxybutyrate Ester (beta-hydroxybutyrate ester)

Snippet

Sponsor: University of Ulm | Conditions: Amyotrophic Lateral Sclerosis | NA | Status: RECRUITING